Abstract
Unlike osteoporosis, renal osteodystrophy offers the promise of recovery as a result of aggressive treatment. We studied long-term bone mineral density (BMD) changes in 364 end- stage renal disease (ESRD) patients in six U.S. dialysis centers. The BMD distribution among ESRD patients at onset is no different from that of the general public. But after a time on dialysis many patients lose BMD at a rate faster than normal. Yet catastrophic BMD loss rates have either been arrested or reversed in many renal patients, a phenomenon quite at variance with patients receiving treatment for osteoporosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Colbert C, Bachtell RS, Mazess RB, Genant HK, et al. in: Cohn SH (ed.): Non-Invasive Measurements of Bone Mass and Their Clinical Application, Boca Raton, FL: CRC Press, 1981, pp. 51–85, 85–99, 121–149.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Publishing Corporation
About this chapter
Cite this chapter
Colbert, C., Bachtell, R., Schloeder, F.X., Feller, H.A., Twardowski, Z.J., Nolph, K.D. (1990). Renal Osteodystrophy Bone Mineral Density Loss and Recovery with Treatment. In: Avram, M.M., et al. Ambulatory Peritoneal Dialysis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9555-7_31
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9555-7_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9557-1
Online ISBN: 978-1-4615-9555-7
eBook Packages: Springer Book Archive